Professor at the Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University. He has conducted research in neuroscience, rehabilitation medicine, and data science, publishing over 100 peer-reviewed papers. His work has been recognized with the Young Scientists’ Prize from the Minister of Education, Culture, Sports, Science and Technology, the Nakatani Award Special Prize, and the Nagase Award Special Prize. He has also served in leading roles such as Executive Board Member of the Clinical BMI Society, Chair of the Organizing Committee for Real-Time Functional Imaging and Neurofeedback 2017, and Jury Chair of the Annual BCI Award 2015. In 2021, he founded LIFESCAPES to take on the challenge of bringing BCI technology into clinical practice and society.

Ph.D. in Science from the Graduate School of Science and Technology, Keio University. After completing his Master’s, he joined DeNA as a new graduate, working on new business development, service planning, corporate sales, and strategic alliances in healthcare, achieving several million dollars in business growth. While working, he earned his doctorate in science from Keio University. In July 2021, he joined LIFESCAPES to bring his research into practical use.
He is also a Research Fellow at the Faculty of Science and Technology, Keio University.

MBA, Globis University Graduate School of Management.
After working in the Information Systems Department at Meiji Yasuda Life Insurance in 2000, he joined an early-stage venture in the swallowing-care industry in 2004. As a leader, he drove the company’s growth into a top player in the field. In 2016, together with the company’s CEO, he acted as an intrapreneur to launch a medical device business within the company, leading management, clinical research, sales, and marketing, and introducing devices for patients with swallowing disorders to hundreds of hospitals nationwide. In 2021, inspired by CEO Ushiba’s vision, he joined LIFESCAPES, taking on the challenge of applying BCI technology in healthcare and bringing it into society.

Ph.D. in Engineering from the Graduate School of Engineering,
Nagoya University. He led research and development in Panasonic’s Advanced Technology Development Division, focusing on artificial intelligence and applications of biosignals, including EEG. He has held his current position since June 2020. He also serves as Auditor for the Japan Society for Artificial Intelligence and as Visiting Professor at Fukui University.

Graduated from the Graduate School of Media and Governance,
Keio University. He joined JAFCO in 2010, focusing on investments in university-originated ventures, and served as Group Leader of the Industry-Academia Collaboration Investment Group and Chief Project Promoter of JST START. In 2020, he joined Beyond Next Ventures as Executive Officer and Partner, leading investments in medical and healthcare fields—including medical devices and digital health—while overseeing a community of deep-tech startup founders.

Graduated from the Faculty of Veterinary Medicine,
Hokkaido University, and earned an MBA from ESADE. He began his career as a veterinarian before joining Eli Lilly in 2010, focusing on sales and marketing of oncology drugs. In 2019, he moved to Elanco, managing post-IPO transitions, integration preparations with Bayer Animal Health, and corporate strategy. In 2020, he joined Keio Innovation Initiative, specializing in drug development, medical devices, and B2B business with healthcare and pharmaceutical stakeholders.

Graduated from the Department of Political Science, School of Law and Politics, Kwansei Gakuin University.
Partner, Investment Department, Mitsui Sumitomo Insurance Venture Capital Co., Ltd.
Since graduating from university, he has spent approximately 35 years engaged in venture capital investment in Japan, working at firms such as NED Co., Ltd. and Yasuda Enterprise Development Co., Ltd. In November 2014, he joined Mitsui Sumitomo Insurance Venture Capital as Partner. Leveraging extensive experience in investment, he actively supports and invests in promising startups aiming for
global expansion, as well as young entrepreneurs dedicated to creating a better
world.

Graduated from the Faculty of Law, Sophia University.
Former Executive Vice President of Kobayashi Pharmaceutical Co., Ltd. and former CEO of its affiliate, Medicon Co., Ltd. Over 40 years in Japan and the U.S., he has led the management and development of medical device companies. Since June 2020, he has been with his current organization and continues to provide strategic management support. He also serves as a Director of the Japan Medical Engineering Manufacturing Commons and the Kobe International Medical Exchange Foundation.

Professor, Department of Rehabilitation Medicine,
Osaka Metropolitan University School of Medicine.

KESIKI INC.